1 – 28 of 28
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
(
- Contribution to journal › Scientific review
- 2023
-
Mark
European consensus for the diagnosis of MCI and mild dementia : Preparatory phase
(
- Contribution to journal › Article
- 2021
-
Mark
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
A multicentre validation study of the diagnostic value of plasma neurofilament light
(
- Contribution to journal › Article
- 2020
-
Mark
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
(
- Contribution to journal › Scientific review
-
Mark
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies
(
- Contribution to journal › Debate/Note/Editorial
- 2019
-
Mark
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
(
- Contribution to journal › Article
-
Mark
GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study
(
- Contribution to journal › Article
- 2018
-
Mark
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
(
- Contribution to journal › Article
- 2017
-
Mark
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort
(
- Contribution to journal › Article
-
Mark
Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations
(
- Contribution to journal › Article
- 2016
-
Mark
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid Alzheimer's disease biomarkers across the spectrum of lewy body diseases : Results from a large multicenter cohort
(
- Contribution to journal › Article
- 2015
-
Mark
Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
(
- Contribution to journal › Article
- 2014
-
Mark
Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study.
(
- Contribution to journal › Article
-
Mark
Determining the Association of the 5HTTLPR Polymorphism with Delusions and Hallucinations in Lewy Body Dementias
(
- Contribution to journal › Article
-
Mark
The cerebrospinal fluid "Alzheimer profile": Easily said, but what does it mean?
(
- Contribution to journal › Article
- 2012
-
Mark
The impact of autonomic dysfunction on survival in patients with dementia with lewy bodies and Parkinson's disease with dementia.
(
- Contribution to journal › Article
-
Mark
A Pilot Study Examining Associations between DYRK1A and alpha-Synuclein Dementias
(
- Contribution to journal › Article
-
Mark
No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias
(
- Contribution to journal › Article
-
Mark
Gender-related differences in the burden of non-motor symptoms in Parkinson's disease
(
- Contribution to journal › Article
- 2011
-
Mark
Quality of Life and the Effect of Memantine in Dementia with Lewy Bodies and Parkinson's Disease Dementia.
(
- Contribution to journal › Article
-
Mark
CSF amyloid beta 38 as a novel diagnostic marker for dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
A Novel Blood Test for the Early Detection of Alzheimer's Disease
(
- Contribution to journal › Article
- 2010
-
Mark
The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia.
(
- Contribution to journal › Article
-
Mark
alpha-synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies
(
- Contribution to journal › Article
- 2009
-
Mark
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
(
- Contribution to journal › Article